AIOCD
All India Organization of Chemists and Druggists (AIOCD) has expressed deep concern over the Central Government’s proposal to permit the sale of Over-The-Counter (OTC) drugs without a license in India.
In a detailed memorandum submitted to the Health Minister, Principal Health Secretary, Drug Controller General of India, Director General of Health Services, Chairman of the National Pharmaceutical Pricing Authority (NPPA), and other relevant authorities, AIOCD highlighted the significant risks associated with this proposal.
AIOCD President, JS Shinde and General Secretary Rajiv Singhal emphasized that such a move would contravene existing drug laws, pharmacy regulations, and pertinent legal frameworks, including directives from the Supreme Court.
Allowing OTC drug sales without proper regulation poses serious threats like dangerous self-medication and drug abuse, increased risk of adverse drug reactions and proliferation of counterfeit drugs and delayed access to healthcare services among others.
AIOCD has urged the government to consider the multifaceted implications of this proposal, emphasizing that unregulated availability of medications in general and grocery stores does not serve the best interests of society.
Union health minister JP Nadda on Saturday said India was at an "exciting juncture" in…
Paras Health has launched Paras Medi Clinic, a community-focused healthcare initiative and Gurugram’s neighbourhood clinic…
In a unique case of showing spirit of Raksha Bandhan, a 24-year-old man has saved…
The national capital reported 138 H1N1 cases in the last 24 hours, taking the cumulative…
The Central Government has imposed restrictions on the manufacture, sale, and distribution of all fixed-dose…
Addressing the 2nd ICC Medical Education Forum, organised by the Indian Chamber of Commerce (ICC) in association…